Dextrose (50%) Injection

[16 May 2016]

Products Affected - Description

50% Dextrose intravenous injection, Amphastar (IMS)
50 mL Luer-Jet syringes, 10 count (NDC 76329-3301-01)
50% Dextrose intravenous injection, Hospira
50 mL LifeShield syringe, 10 count (NDC 00409-4902-34)
50 mL vial, 25 count (NDC 00409-6648-02)

Reason for the Shortage

  • Amphastar has 50% dextrose injection on shortage due to increased demand.
  • Hospira has 50% dextrose injection on shortage due to increased demand and manufacturing delays.

Available Products

50% Dextrose intravenous injection, Hospira
50 mL Ansyr II Luer Lock syringe, 10 count (NDC 00409-7517-16)

Estimated Resupply Dates

  • Amphastar has 50% dextrose 50 mL Luer-Jet syringe on intermittent back order with regular releases.
  • Hospira has 50% dextrose LifeShield 50 mL syringes on back order and the company estimates a release date of mid-May 2016. The 50% dextrose 50 mL vials are available in limited supply.

Related Shortages


May 16 and 5, April 7, January 29 and 20, 2016; December 11, November 4, October 8, September 9, August 24, 17 and 4, July 13, June 10, May 21 and 11, April 27, 2015, University of Utah, Drug Information Service. Copyright 2016, Drug Information Service, University of Utah, Salt Lake City, UT.


This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
ASHP Product Listing